About Benitec Biopharma Limited (adapted from Benitec Biopharma Limited prospectus):
Their ordinary shares are listed on the Australian Securities Exchange under the symbol 'BLT'. On July 24, 2015, the closing price of their ordinary shares on the Australian Securities Exchange was A$0.895 per ordinary share, equivalent to US$13.06 per ADS based on an exchange rate of $1.00 to US$0.7299 (as published by the Reserve Bank of Australia as of July 24, 2015). For the purposes of this preliminary prospectus, the estimated initial public offering price is US$10.00-$10.00 per ADS.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.